- Home
- TTD vs AXSM Comparison
TTD vs AXSM Comparison
Compare TTD & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TTD | AXSM |
|---|---|---|
| Founded | 2009 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.0B | 12.0B |
| IPO Year | 2016 | 2015 |
Fundamental Metrics
Financial Performance| Metric | TTD | AXSM |
|---|---|---|
| Price | $18.58 | $251.33 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 34 | 17 |
| Target Price | $46.22 | ★ $211.12 |
| AVG Volume (30 Days) | ★ 17.7M | 592.3K |
| Earning Date | 05-07-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 15.38 | ★ 38.56 |
| EPS | ★ 0.08 | N/A |
| Revenue | ★ $2,896,284,000.00 | N/A |
| Revenue This Year | $13.94 | $57.24 |
| Revenue Next Year | $12.61 | $55.88 |
| P/E Ratio | $237.13 | ★ N/A |
| Revenue Growth | ★ 18.47 | N/A |
| 52 Week Low | $18.31 | $96.09 |
| 52 Week High | $91.45 | $257.93 |
Technical Indicators
Market Signals| Indicator | TTD | AXSM |
|---|---|---|
| Relative Strength Index (RSI) | 36.34 | 69.21 |
| Support Level | N/A | $148.87 |
| Resistance Level | $24.25 | N/A |
| Average True Range (ATR) | 1.18 | 8.48 |
| MACD | -0.15 | 0.43 |
| Stochastic Oscillator | 5.19 | 83.46 |
Price Performance
Historical ComparisonAbout TTD The Trade Desk Inc.
The Trade Desk provides a self-service platform that helps advertisers and ad agencies programmatically find and purchase digital ad inventory (display, video, audio, and social) on devices like computers, smartphones, and connected TVs. It uses data in an iterative manner to optimize the performance of ad impressions purchased. The firm's platform is referred to as a demand-side platform in the digital ad industry, and it generates revenue from fees based on a percentage of what its clients spend on advertising.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.